Control of Ras activity is crucial for normal cellular behavior such as fate determination during development. Although several GTPase activating proteins (GAPs) have been shown to act as negative regulators of Ras, the mechanisms involved in regulating their activity in vivo are poorly understood. Here we report the structural requirements for Gap1 activity in cone cell fate decisions during Drosophila eye development. The Gap1 catalytic domain alone is not sufficient for in vivo activity, indicating a requirement for the additional domains. An inositol-1,3,4,5-tetrakisphosphate (IP 4 )-sensitive extended PH domain is essential for Gap1 activity, while Ca 2 + -sensitive C2 domains and a glutamine-rich region contribute equally to full activity in vivo. Furthermore, we find a strong positive genetic interaction between Gap1 and phospholipase Cg (PLCg), an enzyme which generates inositol-1,4,5-trisphosphate, a precursor for IP 4 and a second messenger for intracellular Ca 2 + release. These results suggest that Gap1 activity in vivo is stimulated under conditions of elevated intracellular Ca 2 + and IP 4 . Since receptor tyrosine kinases (RTKs) trigger an increase in intracellular Ca 2 + and IP 4 concentration through stimulation of PLCg, RTKs may stimulate not only activation of Ras but also its deactivation by Gap1, thereby moderating the strength and duration of the Ras signal.
Introduction
Ras proteins are small guanine nucleotide-binding polypeptides that associate with the plasma membrane and cycle between an inactive GDP-bound form and a biologically active GTP-bound state. Ras activation is essential for coupling receptor tyrosine kinases to downstream signaling pathways involved in the control of cell proliferation and differentiation, the best characterized of these being the Raf/ MAP kinase pathway (Marshall, 1995) . Ras is activated by guanine nucleotide exchange factors (GNEFs), which catalyze the exchange of GDP for GTP on Ras, while it is negatively regulated by GTPase-activating proteins (GAPs), which hydrolyze Ras-GTP to Ras-GDP. Since strength and duration of Ras signaling is critical for cellular responses to extracellular signals (Marshall, 1995; Greenwood and Struhl, 1997) , it is important to understand how the regulators of Ras activity are themselves regulated.
Activation of Ras proteins following RTK stimulation appears to be achieved largely by translocating the Ras GNEF Sos to the plasma membrane: SH2/SH3 adapter proteins, such as Grb2/Drk, are bound through their SH3 domains to Sos in quiescent cells, and are recruited to the membrane by binding through their SH2 domain to specific phosphorylated tyrosine residues on the activated receptor or associated adapter proteins (for review see Bowtell, 1996) . However, several recent lines of evidence suggest that regulation of Ras GNEF activity is more complex and likely to involve the PH domain in the N-terminus of Sos proteins. In particular, a structure-function analysis of Sos in flies has shown that membrane localization and in vivo activity of Sos requires the N-terminal portion of the molecule which contains the PH and Dbl domains (Karlovich et al., 1995) .
Several GAPs have been identified in both mammals and Drosophila, including neurofibromin, p120Gap and Gap1, which all share a catalytic domain required for stimulating Ras GTPase activity (McCormick, 1995) . However, GAPs possess additional non-catalytic domains which distinguish them from one another and which could be involved in their differential regulation or activity. Neurofibromin appears to constitutively down-regulate Ras, while p120Gap is required for moderating the extent and the duration of Ras activation after growth factor stimulation (DeClue et al., 1992; van der Geer et al., 1997) . This activation in response to growth factor stimulation may be achieved by both membrane translocation and stimulation of its catalytic activity: p120Gap contains SH2 domains which can be induced to bind to the activated RTK, thereby leading to the translocation of the cytoplasmic protein to the membrane (Kazlauskas et al., 1990; Kaplan et al., 1990) . In addition, the Nterminal region of p120Gap appears to be required for full in vitro activity of the C-terminal catalytic domain (Gideon et al., 1992; Bryant et al., 1996) . Gap1, which was first isolated in Drosophila as a negative regulator of RTK signaling, has two homologs in mammals (Gaul et al., 1992; Maekawa et al., 1994; Cullen et al., 1995) . Apart from the catalytic domain in the middle of the molecule, all Gap1 family members share two N-terminal C2 domains and a C-terminal extended PH domain (Fig. 1A ). Biochemical studies with the two mammalian homologs, Gap1 m and Gap1
IP4BP
, have shown that the PH domain, which is required for membrane localization of an N-terminally truncated Gap1 IP4BP (Lockyer et al., 1997) , binds IP 4 or phosphatidylserine (PS) in a mutually exclusive manner (Fukuda and Mikoshiba, 1996; Cullen et al., 1997) , suggesting that an increase in intracellular IP 4 levels leads to the release of the PH domain from the membrane. IP 4 binding to the PH domain also appears to stimulate GAP activity in vitro (Cullen et al., 1995; Fukuda and Mikoshiba, 1996) , implying that release of the PH domain from the membrane is accompanied by activation of the catalytic domain. The N-terminal C2a domain has been shown to bind phospholipids in a Ca 2 + -dependent manner (Fukuda and Mikoshiba, 1996; Fukuda et al., 1997) , while the role of the C2b domain remains unclear. However, the physiological relevance of any of these domains for Gap1 in vivo function has not been established. 
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). The mean of the lines for a particular construct are shown (Table 1 ). The error bars represent the standard error of the mean. Strains isogenic for the second chromosome in the hypomorphic Gap1 S1-11 background were used to determine the mutant baseline (no transgene; Table 1 ).
Here, we report the results from our in vivo functional analysis of Gap1 carried out in the context of cone cell determination in the developing Drosophila eye. This study represents the first structure-function analysis of a GAP protein in vivo. We find that the catalytic domain, in contrast to the full length protein, does not localize to the plasma membrane or provide any rescue activity for Gap1 mutants, suggesting that membrane localization is required for in vivo activity. Furthermore, we show that the PH and the C2 domains, whose IP 4 -and Ca 2 + -sensitivity have been demonstrated in vitro, are required for Gap1 in vivo activity, suggesting stimulation of Gap1 in vivo activity in response to elevated levels of IP 4 and Ca 2 + . This notion is corroborated by the positive synergistic genetic interaction between Gap1 and PLCg, an enzyme which generates IP 3 , a precursor for IP 4 and a second messenger for intracellular Ca 2 + release (Berridge, 1993; Noh et al., 1995) . Since RTK activation triggers the release of intracellular Ca 2 + and IP 4 by stimulation of PLCg, these results implicate for the first time RTK involvement, through PLCg, in the deactivation of Ras by Gap1. Based on these findings we propose that under basal conditions Gap1 is localized to the membrane through its extended PH domain in a less active form; upon elevation of Ca 2 + and IP 4 concentrations, the PH domain binds to IP 4 thereby stimulating catalytic activity, while at the same time the C2a domain takes over the role of membrane tether. This model is supported by the observation that Gap1 appears to be constitutively associated with the plasma membrane.
Results

The experimental paradigm
During normal eye development cone cell precursors are competent to become R7 photoreceptors and will adopt this cell fate if their Ras1 activity level is sufficiently high (Fortini et al., 1992) . Gap1 function is required within the cone cell precursors to down-regulate Ras1 (Buckles et al., 1992; Gaul et al., 1992; Rogge et al., 1992) . Ras activity in these cells is likely elevated to a moderate degree by EGF receptor activity (Begemann et al., 1995; Kramer et al., 1995) . Loss of Gap1 function causes the cone cell precursors to aberrantly adopt the fate of R7 cells (Buckles et al., 1992; Gaul et al., 1992; Rogge et al., 1992) . The number of supernumerary R7 cells produced within each ommatidium depends on the severity of the Gap1 allele (Buckles et al., 1992;  Table 1 ) indicating a sensitivity to different levels of Gap1 activity, which can be exploited for the purposes of a structure-function analysis.
To introduce altered Gap1 transgenes into flies, we used an eye-specific promoter that drives expression in cone cell precursors at appropriate levels: the sevenless (sev) enhancer/promoter cassette (Bowtell et al., 1988; Bowtell et al., 1989; Huang and Fischer-Vize, 1996) . Expression of one copy of wild type Gap1 under control of the sev enhancer/ promoter cassette (sevGap1) rescues the complete loss-offunction eye phenotype (Table 1; Figs 1 and 2) , while creating no phenotypic defects when placed in a wild type background containing two copies of the endogenous Gap1 gene (data not shown). By contrast, high levels of Gap1 expression under sev enhancer/promoter control using amplification by the UAS/GAL4 system in an otherwise wild type background results in a rough eye phenotype due to loss of photoreceptors (Rørth, 1996 ; data not shown). Therefore, fusing altered Gap1 transgenes directly to the sev enhancer/ promoter cassette provides sufficient levels of expression without interfering with development. To assess their rescue ability, transgenes were placed into two different Gap1 mutant backgrounds: the partial loss-of-function allele Gap1 S1-11 and the complete loss-of-function allele Gap1 B2 (Gaul et al., 1992) . Western analysis of larval lysates from partial loss-of-function Gap1 S1-11 mutants show an apparently full length protein whose levels are greatly reduced compared to wildtype (Fig. 3B ) while those from Gap1
B2
show no Gap1-specific protein at all. Transgenic lines were first assayed in the more viable Gap1 S1-11 background; the best rescuing lines from this initial survey were used to test rescue in the null Gap1 B2 background. The residual activity in Gap1 S1-11 provides a sensitized genetic background for the evaluation of dominant negative effects.
Transgene expression levels were evaluated either by Western analysis or by immunhistochemistry in vivo (see Section 4). Transgenic lines tested by Western analysis show expression of proteins of the expected molecular weights (Fig. 3A) . Depending on the particular line, the levels of transgenic protein expression are at most 4-fold higher and at least 2-fold lower than the level produced by the full length Gap1 transgene. However, since doubling transgene copy number does not improve rescue (Table  1) , the transgenes are expressed at saturating levels for activity.
The Gap1 catalytic domain is not sufficient to rescue the loss-of-function phenotype
Previous studies have shown that the GAP domains of p120Gap and neurofibromin have catalytic activity on their own in vitro and are both able to functionally replace IRA1 or IRA2, GTPase-activating proteins for RAS in S. cerevisiae, as well as suppress v-src transformation in intact NIH 3T3 cells (Marshall et al., 1989, McCormick, 1995 and references therein) . Gap1 transgenes containing only the catalytic domain (sevGapM) fail to rescue either the partial or complete loss-of-function phenotype of Gap1 ( Fig. 1 ; Table 1 ). This lack of rescue appears not to be due to protein instability, since a myc-tagged version of the transgene shows robust expression in the eye disc (Fig. 6H ). These findings clearly indicate, in contrast to other studies, that the catalytic domain of Drosophila Gap1 requires additional parts of the protein for in vivo activity. A possible explanation for the difference in results is that, in previous studies, overexpression could have masked the requirement for other portions of the molecule, since all of these studies used strong promoters or high copy number plasmids to express the truncated proteins (cf. Martin et al., 1990; Xu et al., 1990; DeClue et al., 1991) . Another possibility is that the catalytic domain is biochemically inactive. However, this possibility is less likely given the structural and functional conservation among the catalytic domains of various GAPs (Scheffzek et al., 1997) .
The C-terminal, but not the N-terminal portion of Gap1 supports rescue activity
Since the catalytic domain alone could not rescue the loss-of-function phenotype, we tested whether the C-or Nterminal portions were required along with the catalytic domain for in vivo function. In the C-terminus of the molecule two regions can be distinguished. Immediately adjacent to the catalytic domain lies a large stretch of sequence similarity which is shared by all Gap1 family members. This conserved region consists of a PH domain, followed by a Cys 3 His 1 zinc finger, referred to as the BTK motif (Vihinen et al., 1994; Hyvönen and Saraste, 1997) . The PH and BTK sequences are followed by a stretch of 123 amino acids with no known homology to other proteins and poor homology within the Gap1 family; however, since a sequence of eight amino acids (KYGSxxxPIGD) at the C-terminal part of this region is conserved among Gap1 family members, we designate this 123 aa stretch the KYG region. In mammalian Gap1, the BTK/KYG region is required for specific high affinity binding of IP 4 by the PH domain (Fukuda and Mikoshiba, 1996) . C-terminal to the KYG domain is a glutamine-rich stretch found only in the Drosophila homolog.
Transgenes containing the catalytic domain and the entire C-terminus (sevGapDN) show a 50% rescue of the Gap1 partial loss-of-function phenotype ( Fig. 1 ; Table 1 ). The expression level of the sevGapDN transgene providing the most complete rescue is higher than that of the best transgene expressing full length Gap1 (Fig. 3) , indicating that the inability to rescue completely is due to an alteration of intrinsic activity. Thus, in conjunction with the C-terminus, the catalytic domain is sufficient for partial rescue activity. However, the N-terminus is necessary for full in vivo activity, since transgenes lacking the N-terminus do not completely rescue loss-of-function mutants.
The N-terminal region of Drosophila Gap1 possesses two domains with known function, namely C2a and C2b domains. Various transgenes containing just the N-terminus and the catalytic domain (sevGapDPH-Q, sevGapDC and sevGapDBTK-Q) all essentially fail to rescue the mutant phenotype ( Fig. 1 ; Table 1 ). This lack of rescue is not due to protein instability, since a myc-tagged version of the sevGapDBTK-Q transgene shows robust expression in the eye disc (Fig. 6I ). These results demonstrate that, unlike the C-terminus, the N-terminus does not confer the ability to rescue onto the minimal catalytic domain, but is necessary for full rescue activity.
Dissection of the C-terminus: the contributions of the PH/BTK/KYG and glutamine-rich regions
We sought to determine which part of the C-terminus is responsible for endowing the catalytic domain with the ability to rescue. We first tested the importance of the glutamine-rich region. Transgenes without the glutamine-rich region (sevGapDQ) provide 50% rescue (Table 1 ). The expression level of sevGapDQ was similar to that of the full length sevGap1 transgene (Fig. 3) , indicating that the reduction in rescue was indeed due to an alteration in intrinsic activity. Hence, the glutamine-rich region is required for full rescue, but not essential for in vivo activity.
Next, we examined the importance of the PH/BTK/KYG region, beginning with BTK and KYG motifs. The sevGapDBTK-Q transgenes described above lack the entire KYG domain and the last cysteine of the BTK zinc finger as well as the glutamine-rich region and show virtually no rescue. Protein instability was ruled out as the cause for lack of rescue (see above). This finding clearly demonstrates that the BTK and KYG regions are critical for rescue activity.
To examine the role of the PH domain, we introduced a point mutation (sevGap1 R786C ), which severely reduces IP 4 binding in mammalian Gap1 (Fukuda and Mikoshiba, 1996) , and evaluated rescue ability. Like the full length sevGap1 transgenes, sevGap1 R786C transgenes are able to fully rescue the partial loss-of-function situation ( Fig. 1 ; Table 1 ). However, unlike sevGap1, when placed in the complete loss-of-function background, sevGap1 R786C only partially rescues (~70%) the phenotype ( Fig. 4; Table 1 ). In the complete loss-of-function background, the average number of R7s per ommatidium for sevGap1 R786C is 1.6, compared to 1.0 for sevGap1 and 2.9 in the absence of a Gap1 transgene. Thus, the R786C mutation does compromise Gap1 in vivo activity, even if only moderately. The effect of this point mutation is masked by residual activity in the partial loss-of-function situation and is only uncovered in the complete loss-of-function situation. In general, the rescuing ability of Gap1 transgenes is lower in the complete loss-of-function background than in the partial loss-of-function background (with the exception of the sevGapDC2a transgene; see below; Fig. 4) , suggesting that the residual activity in Gap1 S1-11 partially compensates for the loss of activity in mutant Gap1 constructs.
Dissection of the N-terminus: the contributions of the C2 domains
Our results demonstrate that the N-terminus of Gap1 is necessary for full in vivo activity, but only in the presence of critical C-terminal regions, suggesting a modulatory role for the N-terminus. We therefore determined which of the two domains in the N-terminal region, C2a or C2b, are involved in the modulation of activity by separately deleting the entire C2a domain (sevGapDC2a) or half of the C2b domain (sevGapDC2b).
Under complete loss-of-function conditions, transgenes lacking the C2a domain have the same rescue ability as transgenes lacking the entire N-terminus ( Fig. 4 ; Table 1 ). Both sevGapDN 4B and sevGapC2a 8A rescue the null mutant to 50%. This result demonstrates that the C2a domain is required in the N-terminal region for full in vivo activity of Gap1. However, the situation is different under partial loss-of-function conditions. The relative rescuing ability of transgenes lacking the C2a domain is much less than that of transgenes lacking the entire N-terminus: the average number of R7s per ommatidium for sevGapDC2a is 2.2, compared to an average of 1.6 for sevGapDN and of 2.5 without transgene ( Figs. 1 and 4 ; Table 1 ). The comparison of the partial and complete loss-of-function conditions shows that, in the former, residual Gap1 activity interferes with rescue by the sevGapDC2a transgene, indicating that the presence of the C2b domain in the absence of the C2a domain confers a dominant negative activity on the protein. This finding in turn suggests that Gap1 molecules can physically interact either with one another or with other molecules.
Deletion of the C2b domain leads to a complete loss of rescue activity in both the partial and the complete loss-offunction background ( Fig. 1 ; Table 1 ), suggesting that the presence of the C2b domain is crucial for Gap1 in vivo activity. However, the complete failure of the transgenes lacking C2b to rescue is surprising considering the 50% rescue of the complete loss-of-function background by those lacking the entire N-terminus and those lacking just the C2a domain. Transgenes lacking C2b are expressed at levels comparable to that of transgenes lacking C2a (Fig.  3A) , ruling out protein instability. While it is possible that the presence of the C2a domain without the C2b domain inhibits the activity of the rest of the molecule, it seems more likely that the disruption of the C2b domain has a deleterious effect on the remainder of the protein, perhaps through misfolding.
Gap1 genetically interacts with phospholipase Cg
Since the C2 and PH domains, which constitute potential regions of interaction with Ca 2 + and IP 4 , are required for Gap1 in vivo activity, we wondered whether genes involved in Ca 2 + and phosphoinositide signaling regulate Gap1 function in vivo. One such candidate is the small wing (sl) gene in Drosophila which encodes a phospholipase Cg (PLCg) homolog (Emori et al., 1994; Thackeray et al., 1998) .
PLCg is comprised of a catalytic core, two PH, two SH2, and one SH3 domains and a conserved tyrosine phosphorylation site, all of which act as signal-dependent regulators of enzymatic activity (Noh et al., 1995) . Subsequent to RTK stimulation, PLCg is recruited to the receptor through its SH2 domains and then itself activated by tyrosine phosphorylation. Upon activation, PLCg converts phosphatidylinosi- Irvine and Cullen (1993) and references therein).
Loss-of-function mutations in the sl locus display a phenotype which is consistent with PLCg playing a role as a negative regulator of EGFR signaling, similar to Gap1 (Thackeray et al., 1998) . In the eye, sl complete loss-offunction mutations cause a supernumerary R7 phenotype in approximately 30% of ommatidia, which is qualitatively similar to that of Gap1, but much less severe (Fig. 5) . In hemizygous sl 1 mutants, the average number of R7s is 1.3 (Table 2) . Thus, the sl complete loss-of-function phenotype is extremely mild compared to that of Gap1 partial (2.5) or complete (2.9) loss-of-function mutations.
To probe the relationship between PLCg and Gap1, we tested whether they genetically interact. In a wildtype background, Gap1/ + flies are phenotypically wildtype, i.e. all ommatidia have only one R7 cell (Gaul et al., 1992; Lai and Rubin, 1992) , while flies hemizygous for sl 1 and heterozygous for Gap1 (sl/Y; Gap1/ + ) have a supernumerary R7 phenotype greatly enhanced over that seen in hemizygous sl 1 flies (sl/Y;); greater than 80% of ommatidia have multiple R7 cells (Fig. 5) ; +/ + flies (Table 2) . Thus, the phenotype of mutants hemizygous for sl and heterozygous for Gap1 closely resembles that of the partial loss-of-function Gap1 S1-11 allele (2.5; Table 1 ), demonstrating a synergistic positive genetic interaction between sl and Gap1. Given PLCg's role in Ca 2 + and phosphoinositide signaling and Gap1's requirement for its Ca 2 + and IP 4 -sensitive domains, this result suggests that Gap1 activity is positively regulated by PLCg.
Wildtype Gap1 protein is concentrated at the plasma membrane
In order to examine the distribution of Gap1 protein in vivo, we expressed full length Gap1 under the control of the GMR promoter, which drives high levels of expression in all cells posterior to the morphogenetic furrow (Ellis et al., 1993; Hay et al., 1994) . Although sufficient for full in vivo activity and detection by Western analysis, transgene expression under the sev enhancer/promoter cassette or the endogenous promoter were too low for reliable visualization by immunohistochemistry. Confocal microscopy of immunhistochemically stained eye discs reveals that full length Gap1 protein is concentrated at the plasma membrane in all cells, both inside and outside of developing ommatidial clusters (Fig. 6) . Examination of the surface of the eye disc shows Gap1 immunoreactivity marking the apical profiles of all cells posterior to the morphogenetic furrow. Using antibodies against HRP to mark the membrane of neuronal cells (Jan and Jan, 1982) , we find that Gap1 colocalizes with the HRP antigen in the apical microvillar protrusions of photoreceptor cells, which have been shown to be enriched Table 1 Rescue of Gap1 partial and complete loss-of-function phenotypes by mutant Gap1 transgenes. The mean, the SEM, and the number of ommatidia (n) scored are presented for individual transgenic lines in plain text. The average of all transgenic lines for a particular construct are in bold text above the data for individual transgenic lines; here, n represents the number of lines averaged. The 'line' column indicates the particular transgenic line assayed; the transgenes scored mapped to the second chromosome, except where indicated (X indicates an insertion on the X chromosome). The '1 copy; S1-11' column indicates the activity with one copy of the transgene in the Gap1 S1-11 partial loss-of-function background; accordingly, the '2 copies; S1-11' column indicates two copies in the partial loss-of-function background, and the '1 copy; B2' column indicates one copy in the complete loss-of-function (Gap1 B2 ) background. To test for dosage sensitivity, homozygous viable lines with suboptimal rescue were assayed for improvement of rescue. Lines with the best rescue of the partial loss-offunction background were further tested for rescue of the complete loss-of-function background.
Transgene
Line 1 copy; S1-11 n 2 copies; S1-11 n 1 copy; B2 n for membrane-bound signaling molecules such as Sevenless (Tomlinson et al., 1987) . Gap1 also appears to colocalize with the HRP antigen throughout the rest of the cell membrane, including axons. These findings suggest that Gap1 is constitutively localized to the plasma membrane, apparently independent of RTK signaling. Further, we examined the intracellular localization of the myc-tagged versions of GapM (catalytic domain) and GapDBTK-Q (catalytic domain plus the entire N-terminus) transgenes driven by the GMR promoter using a-myc antibodies. We find that both of these truncated proteins fail to localize to the plasma membrane and instead are distributed diffusely throughout the cell (Fig. 6) . Thus, in addition to its requirement for in vivo activity, the C-terminus, which includes the extended PH domain, is essential for membrane localization.
None
Discussion
Control of Ras activity is crucial for normal cellular behavior such as cell fate determination during development. Although GAPs have been shown to act as negative regulators of Ras activity in a number of biological systems, the mechanisms involved in the regulation of GAP activity in vivo are still largely unknown. In order to understand the physiological regulation of the RasGAP Gap1, we determined its primary structural requirements for in vivo activity within the context of cell fate determination during Drosophila eye development.
In contrast to previous studies, we show that the catalytic domain alone is unable to provide any rescue activity for Gap1 loss-of-function mutants, indicating that the flanking Table 1 Transgene Line 1 copy; S1-11 n 2 copies; S1-11 n 1 copy; B2 n 8a 1. S1-11 , and (D,H) sevGap1 3A /CyO; Gap1 S1-11 flies. The scale bars in (A) and (E) represent 100 mm and 5 mm distances, respectively. (Continued) domains are absolutely required for in vivo activity. We propose that these non-catalytic domains are involved in both membrane targeting of the molecule and regulation of its catalytic activity. We find that full length Gap1 is constitutively concentrated at the plasma membrane, and that membrane localization requires the presence of the PH domain-containing C-terminus. Further, we demonstrate that the extended PH domain, which has been shown to be required for membrane binding and for the regulation of the activity of the catalytic domain in Gap1 IP4BP in vitro, is absolutely required for Gap1 in vivo activity.
The role of the PH/BTK/KYG domain
Our finding that the BTK/KYG motifs are essential for Drosophila Gap1 in vivo function agrees in principle with the results of Fukuda and Mikoshiba (1996) which show that the deletion of these motifs, which lie C-terminal to the PH domain in Gap1 m , are essential for IP 4 binding specificity in vitro. The R786C mutation in the PH domain has a less severe effect on in vivo activity in the fly (approx. 30% reduction; Table 1 ) than the corresponding mutation in Gap1 m has on in vitro binding of IP 4 (90% reduction; Fukuda and Mikoshiba, 1996) , probably due to the fact that the transgene is expressed under saturating conditions for activity (see above). Nevertheless, the reduction in Gap1 activity due to this mutation clearly indicates the involvement of the PH domain proper. These findings together with the strong positive genetic interaction between Gap1 and PLCg strongly argue for the importance of IP 4 in the positive regulation of Gap1 in vivo activity.
However, IP 4 can only exert a positive influence on the catalytic activity of Gap1 if other domains within the molecule can mediate its membrane localization, since IP 4 bind- B2 /Df(3L) AC1 background. Ten cephalic complexes (20 eye disk equivalents) were used per lane. The arrows indicate the bands of interest. The mobility of all the transgenic proteins are consistent with their predicted molecular weights. The arrowhead indicates non-Gap1 related cross-reactivity; the level of cross-reactivity is highly variable and does not reflect the number of eye imaginal disks used for each lane. Note that the 80 kDa band in the sevGap1 3A / + lane was highly variable among preparations, if present at all, while the level of the 130 kDa band, representing full length transgenic Gap1, was relatively constant. This 80 kDa band may represent a steady state degradation product. Some of the breakdown products found in wildtype lysates were also seen to varying degrees upon longer exposures with the other transgenes. (B) Comparison of Gap1 protein levels in wildtype (w − ; lane 1) and Gap1 S1-11 (lane 2). Three cephalic complexes were used in each lane. Note that Gap1 levels seen here reflect expression in the larval brain as well as the eye-antennal discs. ing, which results in activation of the catalytic domain, concomitantly leads to the release of the PH domain from the membrane.
The roles of the C2 domains and the glutamine-rich region
The N-terminus of Gap1, while insufficient to support activity of the catalytic domain, is required for full in vivo activity. Since deletion of the C2a domain has the same effect on Gap1 in vivo activity as deletion of the entire Nterminus, we conclude that the C2a domain is required for full in vivo activity. As has been shown for Gap1 m , the C2a domain of Gap1 m binds phosphatidylserine in a Ca 2 + -dependent fashion, making it a possible candidate for a second membrane tether within the molecule (Fukuda and Mikoshiba, 1996; Fukuda et al., 1997 ). An increase in intracellular Ca 2 + would lead to enhanced plasma membrane binding through the C2a domain, thus increasing Gap1 in vivo activity. The strong positive genetic interaction between Gap1 and PLCg further supports this interpretation. PLCg not only promotes the generation of IP 4 but also raises the concentration of Ca 2 + which would allow the C2a domain to bind to the plasma membrane. However, our finding that the truncated protein consisting of the Nterminus and the catalytic domain does not localize to the plasma membrane suggests that the C2a domain can only act as a membrane tether once the molecule is localized to the membrane by the PH domain.
Interestingly, deletion of the C2a domain has a moderate dominant negative effect on Gap1 in vivo activity. This finding suggests that upon removing the C2a domain, the C2b domain interferes with Gap1 function by engaging in a non-productive interaction with either a different ligand or another Gap1 molecule. In support of the latter possibility, the C2b domain of rat synaptotagmin I has been shown to mediate Ca 2 + -dependent dimerization between GST-fusion proteins and native synaptotagmin (Chapman et al., 1996) . It thus seems likely that the C2b domain in Gap1 mediates self-association, and that under conditions of elevated Ca 2 + it may recruit, in conjunction with the C2a domain, other Gap1 molecules to the membrane.
Our structure-function analysis shows that the glutaminerich stretch, which is unique to Drosophila Gap1, is required for full in vivo Gap1 activity. Although it is unclear how the glutamine-rich stretch may function, one possibility is that it also acts as a secondary membrane tether, given that deletion of the N-terminal C2 domains only compromises in vivo activity.
Model of Gap1 activity
How might the domains of Gap1 function together to provide activity in vivo? Our structure-function analysis has shown that the PH/BTK/KYG domain is essential for Gap1 to have any in vivo activity, while the C2a and glutamine-rich domains contribute equally to full activity. The fact that the Ca 2 + -sensitive C2 domains and the IP 4 -sensitive PH/BTK/KYG domain are positively required for Gap1 function, together with the fact that there is a strong positive genetic interaction between Gap1 and PLCg, whose activity leads to the production of IP 4 and release of Ca 2 + , argue that Gap1 activity in vivo is enhanced under conditions of elevated intracellular Ca 2 + and IP 4 . This enhancement may be achieved by both regulation of membrane localization and modulation of the catalytic activity.
Based on our own results and those of others, we propose the following model (Fig. 7A) . Localization of Gap1 to the membrane is mediated by the PH/BTK/KYG superdomain, bringing it proximate to membrane-associated Ras1. An increase in the levels of intracellular Ca 2 + and IP 4 leads to activation of the catalytic domain through IP 4 binding of the PH/BTK/KYG superdomain, which is concomitantly released from the plasma membrane. At the same time, secondary membrane anchoring of the molecule is achieved by the C2a domain, and, possibly, by the glutamine-rich domain. In addition, the C2b domain mediates homodimerization, further augmenting the juxtamembrane concentration of Gap1. According to this model, Gap1 is localized to the plasma membrane under any condition, consistent with the finding that Gap1 appears to be constitutively localized to the plasma membrane.
Implications for Gap1 regulation by RTKs
Our findings argue for a link between RTK/Ras signaling and the second messengers Ca 2 + and inositol phosphates. The in vivo activity of Gap1 is positively regulated by Ca 2 + -and IP 4 -sensitive domains adjacent to its catalytic domain, thereby increasing the intrinsic GTPase activity of Ras and hence negatively regulating its activity. These results strongly suggest a negative regulation of RTK/Ras signaling by Ca 2 + and IP 4 . Intriguingly, one of the signaling events responsible for increases in cytosolic Ca 2 + and IP 4 in non-excitable cells is the activation of RTKs themselves (Berridge, 1993) . Studies in vertebrates show that growth factor-stimulated RTKs, including EGFR, activate PLCg through association with the activated receptor and subsequent phosphorylation (Noh et al., 1995) . Given the structural conservation of EGFR and PLCg between vertebrates and Drosophila (Schejter et al., 1986; Emori et al., 1994) , as well as the functional requirement for both in cone cell precursor development (Begemann et al., 1995; Kramer et al., 1995; Thackeray et al., 1998) , this regulatory relationship is likely preserved. Our observed interaction between Gap1 and PLCg, in conjunction with these findings, suggest that EGFR through PLCg activation could positively influence Gap1 activity (Fig. 7B) . The RTK Torso, whose activity, together with Gap1 and Ras, determines terminal cell fates in the Drosophila embryo (Perrimon, 1993; Hou et al., 1995) , may provide another example for a positive regulatory relationship between RTK, PLCg and Gap1. Torso possesses a conserved PLCg binding site which binds mammalian PLCg showing photoreceptor nuclei devoid of HRP antigen (E) and Gap1 (F), but colocalization of both on photoreceptor membranes (G). (H), (I) 1 mm confocal sections of third instar larval eye discs expressing truncated myc-tagged Gap1 transgenes under GMR promoter control immunohistochemically stained with a-myc antibodies (red). Both the catalytic domain alone (GMR-mycGapM, H) and together with the N-terminus (GMR-mycGapDBTK-Q, I) fail to localize to the plasma membrane.
and whose removal leads to overactivity of in vivo signaling similar to removal of Gap1 (Hou et al., 1995; Cleghon et al., 1996) , suggesting that activation of the Torso RTK stimulates PLCg which, by stimulation of Gap1, could result in the suppression of Ras1 activity.
Thus, if RTKs trigger both activation and deactivation of Ras, then the duration and strength of the Ras signal in response to growth factor stimulation will depend on the kinetics of the pathways involved. Activation of Ras is thought to be achieved largely by membrane localization (and activation) of Sos, which is likely to be fast, whereas the deactivation of Ras by Gap1 may require a more complex series of events, including recruitment and stimulation of PLCg and the IP 3 -mediated increase in intracellular Ca 2 + , which has been shown to be slow and sustained in response to RTK stimulation (Berridge, 1993) .
Experimental
Construction of Gap1 mutant transgenes
Details of transgene construction are available upon request. Standard cloning techniques were used (Sambrook et al., 1989) , and all PCR products used were confirmed by sequencing.
P-element mediated Transformation
Transformation into w 1118 and ry 506 flies was performed essentially as described in Karess and Rubin (1984) .
Genetic strains
The Gap1 S1-11 allele was generated by mobilizing the Pelement insertion in the rI533 line, and Gap1 B2 was isolated as an EMS mutation that increases the effectiveness of temperature-sensitive Sevenless signaling (Gaul et al., 1992) . The Gap1 S1-11 mutation is a partial loss-of-function allele that produces reduced levels (Ͼ10-fold reduction compared to wild type) of full-length protein (Table 1 ; Fig. 3B) ; the Gap1 B2 allele is a genetic and protein null (Gaul et al., 1992 ; Fig. 3A, lane 2) . Both Gap1 alleles and all transgenic lines on the second chromosome were crossed into the w; Bl/ CyO; TM2/TM6B strain to balance both autosomes. Then the balanced transgenic lines were crossed to the balanced Gap1 alleles to establish stable strains. The following strains were also used in this study: Df(3L)AC1, roe/ TM6C, Sb (67D2-3; Bloomington Stock Center), UASGap1 (EP45; P. Rørth), sev-GAL4 (E. Hafen via M. Freeman), sl 1 and sl 2 (Thackeray et al., 1998) .
Plastic sections of adult retinae
Adult fly retinae were embedded and sectioned essentially as described in Cagan and Ready (1989) . Apical sections (20-40 mm from the surface of the eye) from the central region of adult retinae were scored for the average number of R7 cells per ommatidium. At least two to three adult retinae were scored for each transgenic line in the Gap1 S1-11 background. Only transgenes fused to the sevenless enhancer/promoter were used for rescue experiments. To minimize background effects, transgenes mapping to the second chromosome were used, except where indicated. The values for different transgenic lines of a particular mutant were averaged to minimize the influence of P element insertion sites in assessing rescue of the partial loss-offunction Gap1 S1-11 phenotype. The Gap1 S1-11 partial loss-offunction background was used to survey the transgenes since it was easier to obtain adults for analysis. From this analysis, the best rescuing lines were used to determine rescue in complete loss-of-function Gap1 B2 mutants. The strains isogenic for the second chromosome in the hypomorphic Gap1 S1-11 background were used to determine the mutant baseline. Differences between different genotypes were assessed for statistical significance using a Student's t-test (P Ͻ 0.05).
Detection of transgenic proteins
Cephalic complexes from larvae of the appropriate genotype were dissected into PBS plus protease inhibitors (0.18 mg/ml PMSF, 1 mM benzamidine, 5 mg/ml aprotinin, 1 mg/ ml pepstatin, 1 mg/ml leupeptin) at 4°C then placed in sample buffer for SDS-PAGE. Western analysis of transgenic proteins was performed using standard procedures (Sambrook et al., 1989) . Blots were probed with monoclonal antibodies raised against a C-terminal peptide (aa 769-1165) from Gap1 (2C3C3, 6H10C5, 7A8B2 used at 1:300 each; Gaul, unpublished) then detected using chemiluminescence (Pierce). Quantification of protein levels were performed using the ImageQuant program (version 1.1; Molecular Dynamics). We used this method to detect the expression of transgenes bearing the C-terminus (sevGapDN, sevGapDQ, sevGapDC2a, sevGapDC2b, sevGap1) .
To detect transgenic proteins without the C-terminal epitope (GapM and GapDBTK-Q) we fused these constructs to six tandem myc tags and expressed them under the GMR promoter (GMR-GapMmyc and GMR-GapDBTK-Q myc; Ellis et al., 1993; Hay et al., 1994) . Expression was assayed in vivo using an a-myc (9E10) monoclonal antibody (Santa Cruz). Immunohistochemical detection was performed essentially as described in Gaul et al. (1992) , using a-myc at 1:50, Gap1 mouse monoclonal supernatants (Gaul, unpublished data) at 1:2, Cy3-coupled goat a-mouse antibodies (Cappel) at 1:200, and FITC coupled goat a-HRP antibodies (ICN) at 1:25. Confocal images were collected on a Zeiss LSM 510.
Scanning electron microscopy of adult fly eyes
Flies were prepared and micrographed as described in Kimmel et al. (1990) .
